Marisa Frackman

Marisa Frackman has extensive experience in the finance and capital markets industry. Marisa currently serves as the Chief Financial Officer at Sapience Therapeutics, Inc. since February 2022. Prior to that, they worked at Westwicke as the Managing Director, Capital Markets from May 2019 to February 2022. Before joining Westwicke, Marisa held various positions at Wells Fargo Securities, including Director, Healthcare Equity Capital Markets from February 2015 to October 2018, Vice President, Equity Capital Markets from March 2011 to February 2015, and Equity Capital Markets Associate from July 2007 to March 2011. Marisa began their career as an Equity Capital Markets Analyst at Wachovia Securities in 2005 and then moved on to work as a Healthcare Investment Banking Analyst at Deutsche Bank from 2004 to 2005.

Marisa Frackman holds a Bachelor of Science degree in Finance and English from Georgetown University. Marisa also attended the Marymount School of New York, although the degree and field of study are unknown. Additionally, they have obtained a certification in Series 7 from FINRA, although the exact month and year of obtaining the certification are not specified.